endopredict ep (Myriad Genetics)
90
Structured Review
Myriad Genetics
endopredict ep
Endopredict Ep, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict/endopredict+ep/pm40644891-340-0-2
Average 90 stars, based on 1 article reviews
Endopredict Ep, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict/endopredict+ep/pm40644891-340-0-2
Average 90 stars, based on 1 article reviews
endopredict ep - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Microarray:Article Title: Spotlight on the utility of the Oncotype DX<sup>&reg;</sup> breast cancer assay Article Snippet: Soonmyung Paik, the pathologist who contributed to the development of Oncotype DX® (Genomic Health Inc., Redwood City, CA, USA), noted that he developed the multi-gene assay as a result of his frustration with the lack of reproducibility of histological grading and the apparent lack of reliability of community-based HER2 testing during the conduct of a multicenter clinical trial.19 .. There are a number of other commercially available genomic assays including Article Title: Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study Article Snippet: .. Other tests include the Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR) score (Prosigna; NanoString Technologies, Seattle, WA), Article Title: Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review Article Snippet: .. Oncotype DX gene panels (RS; Genomic Health, Redwood City, CA, USA) [ ], Mammaprint [ ] (Agendia, Amsterdam, the Netherlands), other:Article Title: Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery? Article Snippet: The molecular information of Article Title: Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Article Snippet: Background EndoPredict® (EP) is a multigene assay to predict distant recurrence risk in luminal breast cancer.. EP measures the expression of 12 genes in primary tumor by qRT-PCR from formalin-fixed paraffin-embedded (FFPE) tissues and calculates EP risk score that indicates the risk of distant recurrence.. We evaluated the performance of EP in predicting distant recurrence risk using microarray data from fresh frozen (FF) tissues. Article Title: The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes Article Snippet: This review will summarize the clinical utility of several commonly used multiparameter gene expression assays , including the Oncotype DX Recurrence Score (RS) (Genomic Health, Exact Sciences, Madison WI), MammaPrint (Agendia, Inc., Irvine, CA), PAM50 Risk of Recurrence (ROR) score (Prosigna, Veracyte, San Francisco, CA), Control:Article Title: Biomarker discovery for early breast cancer diagnosis using machine learning on transcriptomic data for biosensor development. Article Snippet: .. Quantitative RT-PCR:Article Title: Biomarker discovery for early breast cancer diagnosis using machine learning on transcriptomic data for biosensor development. Article Snippet: .. Formalin-fixed Paraffin-Embedded:Article Title: Biomarker discovery for early breast cancer diagnosis using machine learning on transcriptomic data for biosensor development. Article Snippet: .. |